Human PLacental eXpanded (PLX) mesenchymal-like adherent stromal cells confer neuroprotection to nerve growth factor (NGF)-differentiated PC12 cells exposed to ischemia by secretion of IL-6 and VEGF

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1853, Issue 2, 2015, Pages 422-430

  Lahiani, Adi ^a   Zahavi, Efrat ^b   Netzer, Nir ^b   Ofir, Racheli ^b   Pinzur, Lena ^b   Raveh, Shani ^b   Arien Zakay, Hadar ^a   Yavin, Ephraim ^c   Lazarovici, Philip ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b Pluristem Therapeutics Ltd MATAM Advanced Technology Park 20   (Israel)

^c WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Conditioned medium; Human placental mesenchymal like adherent stromal cells (PLX); IL 6; Ischemia; Neuroprotection; NGF differentiated PC12 cells; Oxygen and glucose deprivation; Reperfusion; Semaxanib; VEGF

Indexed keywords

INTERLEUKIN 6; LACTATE DEHYDROGENASE; NERVE GROWTH FACTOR; SEMAXANIB; VASCULOTROPIN; VASCULOTROPIN 165; AMINE OXIDE; CULTURE MEDIUM; INDOLE DERIVATIVE; MONOCLONAL ANTIBODY; NEUROPROTECTIVE AGENT; PYRROLE DERIVATIVE; SPIN LABELING; TEMPOL; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ARTICLE; BRAIN ISCHEMIA; CELL DEATH; CELL DENSITY; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPID PEROXIDATION; MESENCHYMAL STROMA CELL; MOUSE; NEUROPROTECTION; NONHUMAN; PC12 CELL LINE; PLACENTAL EXPANDED MESENCHYMAL LIKE ADHERENT STROMAL CELL; ANIMAL; CELL ADHESION; CELL COUNT; CULTURE MEDIUM; CYTOLOGY; DRUG EFFECTS; FEMALE; ISCHEMIA; METABOLISM; PATHOLOGY; PHARMACOLOGY; PLACENTA; PREGNANCY; RAT; SECRETION (PROCESS); SPIN LABELING;

ANIMALS; ANTIBODIES, MONOCLONAL; CELL ADHESION; CELL COUNT; CELL DEATH; CELL DIFFERENTIATION; CELL PROLIFERATION; CULTURE MEDIA, CONDITIONED; CYCLIC N-OXIDES; FEMALE; HUMANS; INDOLES; INTERLEUKIN-6; ISCHEMIA; L-LACTATE DEHYDROGENASE; LIPID PEROXIDATION; MESENCHYMAL STROMAL CELLS; MICE; NERVE GROWTH FACTORS; NEUROPROTECTIVE AGENTS; PC12 CELLS; PLACENTA; PREGNANCY; PYRROLES; RATS; SPIN LABELS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84916898576     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2014.11.009     Document Type: Article

References (50)

1. Trounson A., Thakar R.G., Lomax G., Gibbons D. Clinical trials for stem cell therapies. BMC Med. 2011, 9:52.
2. Kranz A., Wagner D.C., Kamprad M., Scholz M., Schmidt U.R., Nitzsche F., Aberman Z., Emmrich F., Riegelsberger U.M., Boltze J. Transplantation of placenta-derived mesenchymal stromal cells upon experimental stroke in rats. Brain Res. 2010, 1315:128-136.
3. Prather W.R., Toren A., Meiron M., Ofir R., Tschope C., Horwitz E.M. The role of placental-derived adherent stromal cell (PLX-PAD) in the treatment of critical limb ischemia. Cytotherapy 2009, 11:427-434.
4. Prather W.R., Toren A., Meiron M. Placental-derived and expanded mesenchymal stromal cells (PLX-I) to enhance the engraftment of hematopoietic stem cells derived from umbilical cord blood. Expert. Opin. Biol. Ther. 2008, 8:1241-1250.
5. Drago D., Cossetti C., Iraci N., Gaude E., Musco G., Bachi A., Pluchino S. The stem cell secretome and its role in brain repair. Biochimie 2013, 95:2271-2285.
6. Arien-Zakay H., Lecht S., Bercu M.M., Tabakman R., Kohen R., Galski H., Nagler A., Lazarovici P. Neuroprotection by cord blood neural progenitors involves antioxidants, neurotrophic and angiogenic factors. Exp. Neurol. 2009, 216:83-94.
7. Lecht S., Rotfeld E., Arien-Zakay H., Tabakman R., Matzner H., Yaka R., Lelkes P.I., Lazarovici P. Neuroprotective effects of nimodipine and nifedipine in the NGF-differentiated PC12 cells exposed to oxygen-glucose deprivation or trophic withdrawal. Int. J. Dev. Neurosci. 2012, 30:465-469.
8. Tabakman R., Lazarovici P., Kohen R. Neuroprotective effects of carnosine and homocarnosine on pheochromocytoma PC12 cells exposed to ischemia. J. Neurosci. Res. 2002, 68:463-469.
9. Lipman T., Tabakman R., Lazarovici P. Neuroprotective effects of the stable nitroxide compound Tempol on 1-methyl-4-phenylpyridinium ion-induced neurotoxicity in the nerve growth factor-differentiated model of pheochromocytoma PC12 cells. Eur. J. Pharmacol. 2006, 549:50-57.
10. Abu-Raya S., Tabakman R., Blaugrund E., Trembovler V., Lazarovici P. Neuroprotective and neurotoxic effects of monoamine oxidase-B inhibitors and derived metabolites under ischemia in PC12 cells. Eur. J. Pharmacol. 2002, 434:109-116.
11. Tabakman R., Jiang H., Levine R.A., Kohen R., Lazarovici P. Apoptotic characteristics of cell death and the neuroprotective effect of homocarnosine on pheochromocytoma PC12 cells exposed to ischemia. J. Neurosci. Res. 2004, 75:499-507.
12. Schonfeld E., Yasharel I., Yavin E., Brand A. Docosahexaenoic acid enhances iron uptake by modulating iron transporters and accelerates apoptotic death in PC12 cells. Neurochem. Res. 2007, 32:1673-1684.
13. Bercu M.M., Arien-Zakay H., Stoler D., Lecht S., Lelkes P.I., Samuel S., Or R., Nagler A., Lazarovici P., Elchalal U. Enhanced survival and neurite network formation of human umbilical cord blood neuronal progenitors in three-dimensional collagen constructs. J. Mol. Neurosci. 2013, 51:249-261.
14. Huang Y.C., Yang Z.M., Chen X.H., Tan M.Y., Wang J., Li X.Q., Xie H.Q., Deng L. Isolation of mesenchymal stem cells from human placental decidua basalis and resistance to hypoxia and serum deprivation. Stem Cell Rev. 2009, 5:247-255.
15. Hong H., Liu G.Q. Protection against hydrogen peroxide-induced cytotoxicity in PC12 cells by scutellarin. Life Sci. 2004, 74:2959-2973.
16. Kruman I., Bruce-Keller A.J., Bredesen D., Waeg G., Mattson M.P. Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis. J. Neurosci. 1997, 17:5089-5100.
17. Joyce N., Annett G., Wirthlin L., Olson S., Bauer G., Nolta J.A. Mesenchymal stem cells for the treatment of neurodegenerative disease. Regen. Med. 2010, 5:933-946.
18. Uccelli A., Benvenuto F., Laroni A., Giunti D. Neuroprotective features of mesenchymal stem cells. Best Pract. Res. Clin. Haematol. 2011, 24:59-64.
19. Hsieh J.Y., Wang H.W., Chang S.J., Liao K.H., Lee I.H., Lin W.S., Wu C.H., Lin W.Y., Cheng S.M. Mesenchymal stem cells from human umbilical cord express preferentially secreted factors related to neuroprotection, neurogenesis, and angiogenesis. PLoS One 2013, 8:e72604.
20. Acosta S.A., Tajiri N., Shinozuka K., Ishikawa H., Sanberg P.R., Sanchez-Ramos J., Song S., Kaneko Y., Borlongan C.V. Combination therapy of human umbilical cord blood cells and granulocyte colony stimulating factor reduces histopathological and motor impairments in an experimental model of chronic traumatic brain injury. PLoS One 2014, 9:e90953.
21. Dela Pena I., Sanberg P.R., Acosta S., Tajiri N., Lin S.Z., Borlongan C.V. Stem cells and G-CSF for treating neuroinflammation in traumatic brain injury: aging as a comorbidity factor. J. Neurosurg. Sci. 2014, 58:145-149.
22. Tajiri N., Acosta S.A., Shahaduzzaman M., Ishikawa H., Shinozuka K., Pabon M., Hernandez-Ontiveros D., Kim D.W., Metcalf C., Staples M., Dailey T., Vasconcellos J., Franyuti G., Gould L., Patel N., Cooper D., Kaneko Y., Borlongan C.V., Bickford P.C. Intravenous transplants of human adipose-derived stem cell protect the brain from traumatic brain injury-induced neurodegeneration and motor and cognitive impairments: cell graft biodistribution and soluble factors in young and aged rats. J. Neurosci. 2014, 34:313-326.
23. Ryu S., Seol G.H., Park H., Choi I.Y. Trans-anethole protects cortical neuronal cells against oxygen-glucose deprivation/reoxygenation. Neurol. Sci. 2014, 35(10):1541-1547.
24. Barone F.C., Irving E.A., Ray A.M., Lee J.C., Kassis S., Kumar S., Badger A.M., Legos J.J., Erhardt J.A., Ohlstein E.H., Hunter A.J., Harrison D.C., Philpott K., Smith B.R., Adams J.L., Parsons A.A. Inhibition of p38 mitogen-activated protein kinase provides neuroprotection in cerebral focal ischemia. Med. Res. Rev. 2001, 21:129-145.
25. Jia D., Han B., Yang S., Zhao J. Anemonin alleviates nerve injury after cerebral ischemia and reperfusion (i/r) in rats by improving antioxidant activities and inhibiting apoptosis pathway. J. Mol. Neurosci. 2014, 53:271-279.
26. Tate C.C., Fonck C., McGrogan M., Case C.C. Human mesenchymal stromal cells and their derivative, SB623 cells, rescue neural cells via trophic support following in vitro ischemia. Cell Transplant. 2010, 19:973-984.
27. Zhong Q., Zhou Y., Ye W., Cai T., Zhang X., Deng D.Y. Hypoxia-inducible factor 1-alpha-AA-modified bone marrow stem cells protect PC12 cells from hypoxia-induced apoptosis, partially through VEGF/PI3K/Akt/FoxO1 pathway. Stem Cells Dev. 2012, 21:2703-2717.
28. Lu S., Lu C., Han Q., Li J., Du Z., Liao L., Zhao R.C. Adipose-derived mesenchymal stem cells protect PC12 cells from glutamate excitotoxicity-induced apoptosis by upregulation of XIAP through PI3-K/Akt activation. Toxicology 2011, 279:189-195.
29. Liu L., Cao J.X., Sun B., Li H.L., Xia Y., Wu Z., Tang C.L., Hu J. Mesenchymal stem cells inhibition of chronic ethanol-induced oxidative damage via upregulation of phosphatidylinositol-3-kinase/Akt and modulation of extracellular signal-regulated kinase 1/2 activation in PC12 cells and neurons. Neuroscience 2010, 167:1115-1124.
30. Francois S., Mouiseddine M., Allenet-Lepage B., Voswinkel J., Douay L., Benderitter M., Chapel A. Human mesenchymal stem cells provide protection against radiation-induced liver injury by antioxidative process, vasculature protection, hepatocyte differentiation, and trophic effects. Biomed. Res. Int. 2013, 2013:151679.
31. Kunioku H., Inoue K., Tomida M. Interleukin-6 protects rat PC12 cells from serum deprivation or chemotherapeutic agents through the phosphatidylinositol 3-kinase and STAT3 pathways. Neurosci. Lett. 2001, 309:13-16.
32. Umegaki H., Yamada K., Naito M., Kameyama T., Iguchi A., Nabeshima T. Protective effect of interleukin-6 against the death of PC12 cells caused by serum deprivation or by the addition of a calcium ionophore. Biochem. Pharmacol. 1996, 52:911-916.
33. Nakajima A., Yamada K., Zou L.B., Yan Y., Mizuno M., Nabeshima T. Interleukin-6 protects PC12 cells from 4-hydroxynonenal-induced cytotoxicity by increasing intracellular glutathione levels. Free Radic. Biol. Med. 2002, 32:1324-1332.
34. Yamada K., Umegaki H., Maezawa I., Iguchi A., Kameyama T., Nabeshima T. Possible involvement of catalase in the protective effect of interleukin-6 against 6-hydroxydopamine toxicity in PC12 cells. Brain Res. Bull. 1997, 43:573-577.
35. Shimma N., Akiyama N., Umezawa M., Okuma Y., Nomura Y., Saito T., Horie S., Murayama T. Possible role of interleukin-6 in PC12 cell death induced by MPP+ and tetrahydroisoquinoline. J. Pharmacol. Sci. 2003, 93:471-477.
36. Lazarovici P., Marcinkiewicz C., Lelkes P.I. Cross talk between the cardiovascular and nervous systems: neurotrophic effects of vascular endothelial growth factor (VEGF) and angiogenic effects of nerve growth factor (NGF)-implications in drug development. Curr. Pharm. Des. 2006, 12:2609-2622.
37. Yang S.P., Kwon B.O., Gho Y.S., Chae C.B. Specific interaction of VEGF165 with beta-amyloid, and its protective effect on beta-amyloid-induced neurotoxicity. J. Neurochem. 2005, 93:118-127.
38. Jin K.L., Mao X.O., Greenberg D.A. Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:10242-10247.
39. Borlongan C.V., Kaneko Y., Maki M., Yu S.J., Ali M., Allickson J.G., Sanberg C.D., Kuzmin-Nichols N., Sanberg P.R. Menstrual blood cells display stem cell-like phenotypic markers and exert neuroprotection following transplantation in experimental stroke. Stem Cells Dev. 2010, 19:439-452.
40. Emerich D.F., Silva E., Ali O., Mooney D., Bell W., Yu S.J., Kaneko Y., Borlongan C. Injectable VEGF hydrogels produce near complete neurological and anatomical protection following cerebral ischemia in rats. Cell Transplant. 2010, 19:1063-1071.
41. Chatterjee P.K., Cuzzocrea S., Brown P.A., Zacharowski K., Stewart K.N., Mota-Filipe H., Thiemermann C. Tempol, a membrane-permeable radical scavenger, reduces oxidant stress-mediated renal dysfunction and injury in the rat. Kidney Int. 2000, 58:658-673.
42. Wilcox C.S. Effects of tempol and redox-cycling nitroxides in models of oxidative stress. Pharmacol. Ther. 2010, 126:119-145.
43. Scheibe F., Klein O., Klose J., Priller J. Mesenchymal stromal cells rescue cortical neurons from apoptotic cell death in an in vitro model of cerebral ischemia. Cell. Mol. Neurobiol. 2012, 32:567-576.
44. Hao L., Zou Z., Tian H., Zhang Y., Zhou H., Liu L. Stem cell-based therapies for ischemic stroke. Biomed. Res. Int. 2014, 2014:468748.
45. Parr A.M., Tator C.H., Keating A. Bone marrow-derived mesenchymal stromal cells for the repair of central nervous system injury. Bone Marrow Transplant. 2007, 40:609-619.
46. Kupcova Skalnikova H. Proteomic techniques for characterisation of mesenchymal stem cell secretome. Biochimie 2013, 95:2196-2211.
47. Sze S.K., de Kleijn D.P., Lai R.C., Khia Way Tan E., Zhao H., Yeo K.S., Low T.Y., Lian Q., Lee C.N., Mitchell W., El Oakley R.M., Lim S.K. Elucidating the secretion proteome of human embryonic stem cell-derived mesenchymal stem cells. Mol. Cell. Proteomics 2007, 6:1680-1689.
48. Svensson B., Peters M., Konig H.G., Poppe M., Levkau B., Rothermundt M., Arolt V., Kogel D., Prehn J.H. Vascular endothelial growth factor protects cultured rat hippocampal neurons against hypoxic injury via an antiexcitotoxic, caspase-independent mechanism. J. Cereb. Blood Flow Metab. 2002, 22:1170-1175.
49. Yamashita T., Sawamoto K., Suzuki S., Suzuki N., Adachi K., Kawase T., Mihara M., Ohsugi Y., Abe K., Okano H. Blockade of interleukin-6 signaling aggravates ischemic cerebral damage in mice: possible involvement of Stat3 activation in the protection of neurons. J. Neurochem. 2005, 94:459-468.
50. Sakata H., Narasimhan P., Niizuma K., Maier C.M., Wakai T., Chan P.H. Interleukin 6-preconditioned neural stem cells reduce ischaemic injury in stroke mice. Brain 2012, 135:3298-3310.